S Bandla et al. reported that the level of EGFR and VEGFA changed in the two types of esophageal cancer; esophageal squamous cell carcinoma, predominant globally, and esophageal adenocarcinoma (24). This evidence concerns the gene EGFR and esophageal adenocarcinoma.